Day: January 1, 2022

Jan 01
J&J's COVID-19 vaccine booster was 85% effective against hospitalization, in South Africa study

Johnson & Johnson JNJ, -0.72% said Thursday that a South African Phase 3 study showed that its a booster shot of its COVID-19 vaccine was 85% effective in preventing COVID-19-related hospitalization. The drug maker said the study, conducted by the South African Medical Research Council, was conducted from mid-November to mid-December, which is after omicron […]

Jan 01
Kroger stock rises after new $1 billion stock buyback program authorized

Shares of Kroger Co. KR, +0.27% rose 0.9% in premarket trading Thursday, putting them on track for a fourth-straight gain, after the supermarket operator announced a new $1 billions stock repurchase program. The company said the new program replaces the current program, which had about $157 million remaining. The new program represents roughly 3% of […]

Jan 01
Royal Caribbean plays down impact of omicron on cruises, longer-term results and stock rallies

Shares of Royal Caribbean Group RCL, -0.58% jumped 1.7% in morning trading Thursday, after the cruise operator looked to play down the impact of the omicron variant of the coronavirus on cruises, saying the impact on bookings has been less than what was experienced with the delta variant. The company said near-term results will be […]

Jan 01
Coronavirus tally: Parabolic surge in average daily cases continues, and hospitalizations top 80,000

The seven-day average of COVID-19 cases in the U.S. continued its parabolic climb to 344,543 on Thursday, up from 301,477 on Wednesday, up about four-fold since Dec. 1 and 37% above the January 2021 daily peak of 251,232, according to a New York Times tracker. Hospitalizations also kept climbing, but at a slower pace, as […]

Jan 01
U.K. approves Pfizer oral antiviral Paxlovid for COVID-19

The U.K. Medicines and Healthcare products Regulatory Agency said it’s approved Pfizer’s PFE, +1.11% Paxlovid oral antiviral for people with mild to moderate COVID-19 and have at least one risk factor for developing severe illness. The regulator last month had approved Merck’s MRK, -0.65% Lagevrio. The regulator said it is too early to know whether […]

Jan 01
Zepp Health's stock drops after revenue outlook cut, citing COVID effect and chip shortage

Shares of Zepp Health Corp. ZEPP, dropped 4.0% in premarket trading Friday, after the China-based smart health technology company cut its fourth-quarter revenue outlook, citing a “greater than anticipated effects of COVID” and a more persistent global shortage of semiconductors. The company now expects fourth-quarter revenue of between RMB1.6 billion ($252.0 million) and RMB1.75 billion […]

Jan 01
The FSMA identifies 27 new websites of fraudulent lenders

The Financial Services and Markets Authority (FSMA) warns the public against the activities of unauthorized lenders who offer false credits to consumers. The FSMA continues its investigation into fraudulent credit websites and manages to track down 27 websites of fraudulent lenders. The scam remains the same. Consumers get thus in touch with these providers in a […]

Jan 01
Press release on the reopening of trading in Recticel

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Recticel, ISIN BE0003656676, on Euronext Brussels will re-open on 13/10/2021 at 10:00 CET. Source: FSMA

Jan 01
Press release on the reopening of trading in Xior

ANNOUNCEMENT BY THE FINANCIAL SERVICES AND MARKETS AUTHORITY, PUBLISHED IN APPLICATION OF ARTICLE 78 OF THE LAW OF 21 NOVEMBER 2017 Trading in the financial instruments of Xior, ISIN BE0974288202 on Euronext Brussels will re-open on 12/10/2021 at 09:00 CET. Source: FSMA

Jan 01
Voluntary public takeover bid by XIOR Student Housing NV on Quares Student Housing NV

This press release is not available in English. Please consult the French or Dutch site. Source: FSMA